Correspondence
Response to the ACMD's report on remimazolam (Byfavo)
The government responds to a report by the Advisory Council on the Misuse of Drugs (ACMD) regarding the classification and schedule of remimazolam (Byfavo).
Documents
Details
A letter from the Minister of State for Crime, Policing and Fire to the Advisory Council on the Misuse of Drugs (ACMD), responding to the ACMD’s advice in December 2022 regarding the classification and schedule of remimazolam (Byfavo).
Published 2 March 2023